Plunkett Research Online: Genomma Lab Internacional SAB de CV

GENOMMA LAB INTERNACIONAL SAB DE CV (GNMLF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Genomma Lab Internacional SAB de CV is a network of businesses and institutions that conduct research, manufacture and market pharmaceutical and dermo-cosmetic products. The firm’s product portfolio includes more than 70 brands, of which many have been launched throughout the U.S. and Latin America.....



Genomma Lab Internacional SAB de CV
Ticker: GNMLF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 52 5550810000
Fax:
Address: Samara Building
Antonio Dovalí Jaime No, 70 Piso 2
Col. Santa Fé
Mexico, CP 01210 Mexico

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription

Maximo JudaCEO
Antonio Zamora GallandCFO
See More
Genomma Lab Internacional SAB de CV is a network of businesses and institutions that conduct research, manufacture and market pharmaceutical and dermo-cosmetic products. The firm’s product portfolio includes more than 70 brands, of which many have been launched throughout the U.S. and Latin America.....See More See More

Auditor: Deloitte Touche Tohmatsu Limited
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors:

The company offers employees medical service, bonuses, life insurance, paternity leave, a pension fund and stock options.